Home/Filings/4/0001209191-18-041303
4//SEC Filing

Mulroy Michael H. 4

Accession 0001209191-18-041303

CIK 0000876343other

Filed

Jul 2, 8:00 PM ET

Accepted

Jul 3, 6:22 PM ET

Size

11.3 KB

Accession

0001209191-18-041303

Insider Transaction Report

Form 4
Period: 2018-07-01
Transactions
  • Award

    Option to Purchase Common Shares

    2018-07-01+40,00040,000 total
    Exercise: $2.06Exp: 2023-06-30Common Shares (40,000 underlying)
Holdings
  • Option to Purchase Common Shares

    Exercise: $3.29Exp: 2019-10-03Common Shares (20,000 underlying)
    20,000
  • Option to Purchase Common Shares

    Exercise: $3.15Exp: 2022-06-30Common Shares (20,000 underlying)
    20,000
  • Option to Purchase Common Shares

    Exercise: $2.72Exp: 2021-06-30Common Shares (20,000 underlying)
    20,000
  • Common Shares, no par value

    32,550
  • Option to Purchase Common Shares

    Exercise: $3.57Exp: 2020-06-30Common Shares (20,000 underlying)
    20,000
Footnotes (5)
  • [F1]Will become exercisable on June 30, 2019, based upon continued service on the board of directors.
  • [F2]Became exercisable in four equal quarterly installments after the date of grant on July 1, 2017.
  • [F3]Became exercisable in four equal quarterly installments after the date of grant on July 1, 2016.
  • [F4]Became exercisable in four equal quarterly installments after the date of grant on July 1, 2015.
  • [F5]Became exercisable in four equal quarterly installments after the date of grant on October 4, 2014.

Issuer

BIOTIME INC

CIK 0000876343

Entity typeother

Related Parties

1
  • filerCIK 0001509725

Filing Metadata

Form type
4
Filed
Jul 2, 8:00 PM ET
Accepted
Jul 3, 6:22 PM ET
Size
11.3 KB